Pan Hu

An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.

Mingyao Liu, Z. Yi, Yihua Chen, 2021, Cancer letters.

Design, synthesis and evaluation of phenylthiazole and phenylthiophene pyrimidindiamine derivatives targeting the bacterial membrane.

Mingyao Liu, Z. Yi, Yihua Chen, 2020, European journal of medicinal chemistry.

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy

Mingyao Liu, Z. Yi, Weiqiang Lu, 2021, Clinical Cancer Research.

Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain

Mingyao Liu, Yundong He, Z. Yi, 2020, Cell Biology and Toxicology.

Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity

Mingyao Liu, Z. Yi, Shifen Xu, 2020, Planta Medica.

5-Hydroxymethylfurfural Ameliorates Allergic Inflammation in HMC-1 Cells by Inactivating NF-κB and MAPK Signaling Pathways

Pan Hu, Yinglin Wang, Zhuo-bo Zhang, 2023, Biochemical genetics.

WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17.

Huang Chen, Aiwu Bian, Pan Hu, 2023, International immunopharmacology.